✦ LIBER ✦

Combination therapy with capecitabine, epirubicin and docetaxel reduces tumour size

Book ID: 120870371
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2000
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200012400-00042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine in combination with docetax

Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma

✍ Marco Venturini; Antonio Durando; Ornella Garrone; Maria Antonietta Colozza; Ant 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to evaluate the activity and safety of oral capecitabine in combination with docetaxel and epirubicin (TEX) as first‐line treatment for patients with locally advanced/metastatic breast carcinoma. ## METHODS This open‐label, Phase II study

Adjuvant capecitabine in combination wit

Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial

✍ Heikki Joensuu; Pirkko-Liisa Kellokumpu-Lehtinen; Riikka Huovinen; Arja Jukkola- 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 178 KB

Capecitabine plus docetaxel combination

Capecitabine plus docetaxel combination therapy : Cost-effectiveness in patients with anthracycline-pretreated advanced breast carcinoma

✍ Shailendra Verma; Dominique Maraninchi; Joyce O'Shaughnessy; Carol Jamieson; Ste 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

Capecitabine in combination with docetax

Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial

✍ Ernst, T; Merx, K; Gnad-Vogt, U; Lukan, N; Kripp, M; Schultheis, B; Hochhaus, A; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 106 KB

A phase I clinical and pharmacokinetic s

A phase I clinical and pharmacokinetic study of capecitabine (Xeloda®) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours

✍ Delord, J P; Pierga, J Y; Dieras, V; Bertheault-Cvitkovic, F; Turpin, F L; Lokie 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB

Combination of Docetaxel, Epirubicin and

Combination of Docetaxel, Epirubicin and Vinorelbine Administered Every 2 Weeks as First-line Therapy in Patients with Metastatic Breast Cancer: A Dose-finding Study

✍ Emilio Esteban; Antonio Modollel; Luis González de Sande; Isabel Palacio; Isabel 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 130 KB